Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial (Q38603287)

From Wikidata

Jump to navigation Jump to search

scientific article published on 25 August 2017

Language	Label	Description	Also known as
English	Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial	scientific article published on 25 August 2017

Statements

scholarly article

1 reference

Europe PubMed Central

4 September 2017

Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial (English)

1 reference

Europe PubMed Central

4 September 2017

revascularization

1 reference

based on heuristic

inferred from title

11

object named as

Ron Waksman

1 reference

Europe PubMed Central

4 September 2017

Donald E Cutlip

10

object named as

Donald E Cutlip

1 reference

Europe PubMed Central

4 September 2017

2

object named as

Laura Mauri

1 reference

Europe PubMed Central

4 September 2017

Hector M Garcia-Garcia

6

object named as

Hector M Garcia-Garcia

1 reference

Europe PubMed Central

4 September 2017

David E Kandzari

1

object named as

David E Kandzari

1 reference

Europe PubMed Central

4 September 2017

Joseph M Massaro

4

object named as

Joseph M Massaro

1 reference

Europe PubMed Central

4 September 2017

5

object named as

Gheorghe Doros

1 reference

Europe PubMed Central

4 September 2017

3

object named as

Jacques J Koolen

1 reference

Europe PubMed Central

4 September 2017

8

object named as

Ariel Roguin

1 reference

Europe PubMed Central

4 September 2017

author name string

Johan Bennett

7

1 reference

Europe PubMed Central

4 September 2017

Elie G Gharib

9

1 reference

Europe PubMed Central

4 September 2017

BIOFLOW V Investigators

12

1 reference

Europe PubMed Central

4 September 2017

language of work or name

0 references

publication date

25 August 2017

1 reference

Europe PubMed Central

4 September 2017

1 reference

Europe PubMed Central

4 September 2017

Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932249-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Very late stent thrombosis and late target lesion revascularization after sirolimus-eluting stent implantation: five-year outcome of the j-Cypher Registry

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932249-3

7 January 2021

based on heuristic

inferred from DOI database lookup

2-year clinical and angiographic outcomes from a randomized trial of polymer-free dual drug-eluting stents versus polymer-based Cypher and Endeavor [corrected] drug-eluting stents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932249-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Two-year clinical, angiographic, and intravascular ultrasound follow-up of the XIENCE V everolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932249-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Late restenosis following sirolimus-eluting stent implantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932249-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Five-year clinical and angiographic outcomes of a randomized comparison of sirolimus-eluting and paclitaxel-eluting stents: results of the Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization LATE trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932249-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932249-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Examination of the in vivo mechanisms of late drug-eluting stent thrombosis: findings from optical coherence tomography and intravascular ultrasound imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932249-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932249-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Pathology of second-generation everolimus-eluting stents versus first-generation sirolimus- and paclitaxel-eluting stents in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932249-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Hypersensitivity reaction in the US Food and Drug Administration-approved second-generation drug-eluting stents: histopathological assessment with ex vivo optical coherence tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932249-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932249-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932249-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized, non-inferiority trial of three limus agent-eluting stents with different polymer coatings: the Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus-Eluting Stents (ISAR-TEST-4) Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932249-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent (COMPARE II): a randomised, controlled, non-inferiority trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932249-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent: a randomized, controlled, noninferiority trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932249-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stent: the EVOLVE II Randomized Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932249-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved Safety and Reduction in Stent Thrombosis Associated With Biodegradable Polymer-Based Biolimus-Eluting Stents Versus Durable Polymer-Based Sirolimus-Eluting Stents in Patients With Coronary Artery Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932249-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized, prospective, intercontinental evaluation of a bioresorbable polymer sirolimus-eluting coronary stent system: the CENTURY II (Clinical Evaluation of New Terumo Drug-Eluting Coronary Stent System in the Treatment of Patients with Coronar

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932249-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of a novel biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: results of the randomized BIOFLOW-II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932249-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932249-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Histopathological comparison of biodegradable polymer and permanent polymer based sirolimus eluting stents in a porcine model of coronary stent implantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932249-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Review: Bioresorbable polymeric stents: current status and future promise

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932249-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical end points in coronary stent trials: a case for standardized definitions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932249-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Myocardial infarction adjudication in contemporary all-comer stent trials: balancing sensitivity and specificity. Addendum to the historical MI definitions used in stent studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932249-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The BUGS project: Evolution, critique and future directions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932249-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932249-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932249-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932249-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932249-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Tissue response to partially in vitro predegraded poly-L-lactide implants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932249-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932249-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Strut tissue coverage and endothelial cell coverage: a comparison between bare metal stent platforms and platinum chromium stents with and without everolimus-eluting coating

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932249-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932249-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932249-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932249-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932249-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized comparison of the Endeavor zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932249-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Final 5-year outcomes from the Endeavor zotarolimus-eluting stent clinical trial program: comparison of safety and efficacy with first-generation drug-eluting and bare-metal stents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932249-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932249-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized Comparison of a Biodegradable Polymer Ultrathin Strut Sirolimus-Eluting Stent With a Biodegradable Polymer Biolimus-Eluting Stent in Patients Treated With Percutaneous Coronary Intervention: The SORT OUT VII Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932249-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(17)32249-3

1 reference

Europe PubMed Central

4 September 2017

1 reference

Europe PubMed Central

4 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38603287&oldid=1904995706"